Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

EEO. 2022; 21(2): 155-163


Evaluation Of The Effectiveness Of Schema Therapy On Reducing Anxiety And Chronic Depression Symptoms In Students

Mehri Jalali Rigi,Fereshteh Rezaei Nasab,Fatemeh Esmaili,Seyed ata olya,Hamid Rostami.




Abstract

Background and Aim: Depressive and anxiety disorders are the most common psychiatric disorders in the general population that have increased critically. Schema therapy is designed as one of the important treatment methods to treat these disorders. Therefore, the present study was conducted to investigate the effectiveness of schema therapy on reducing the symptoms of anxiety and chronic depression in students.

Methods: The present study is applied in terms of purpose and semi-experimental in terms of method with pre-test and post-test design with control group. The statistical population of this study included all male and female students referred to the counseling center of Islamic Azad University, Tehran Research Sciences Branch. A total of 40 students with anxiety disorder and depression were selected by available sampling method and randomly assigned to experimental and control groups (20 people in each group). The experimental group was trained in 8 90-minute sessions using schema therapy. All groups completed the Cattell Anxiety and Beck Depression Inventory as a pretest, posttest, and one-month follow-up. Data were analyzed by multivariate covariance (Mankova) method.

Results: The findings of this study showed that the symptoms of anxiety disorder and depression in the experimental group, unlike the control group in the post-test and one-month follow-up stages were significantly reduced (p

Key words: Schema therapy, Anxiety, Depression, Students






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.